WallStreetZenWallStreetZen

NASDAQ: RGEN
Repligen Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

RGEN past earnings growth

How has RGEN's earnings growth performed historically?
Company
-77.61%
Industry
22.79%
Market
107.64%
RGEN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RGEN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
RGEN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

RGEN past revenue growth

How has RGEN's revenue growth performed historically?
Company
-20.31%
Industry
7.99%
Market
17.61%
RGEN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RGEN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RGEN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RGEN earnings and revenue history

Current Revenue
$638.8M
Current Earnings
$41.6M
Current Profit Margin
6.5%
RGEN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

RGEN Return on Equity

Current Company
2.1%
Current Industry
11.1%
Current Market
188%
RGEN's Return on Equity (2.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RGEN announces earnings.

RGEN Return on Assets

Current Company
1.6%
Current Industry
7.2%
RGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RGEN Return on Capital Employed

Current Company
2.48%
Current Industry
9.7%
RGEN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RGEN vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RGEN$638.76M$134.17M$41.58M+26.91%+14.57%
STVN$1.18B$325.43M$158.29M+18.93%+35.74%
ATR$3.49B$664.15M$284.49M+4.75%+6.82%
TFX$2.97B$759.97M$356.33M+3.97%+11.54%
XRAY$3.97B$249.00M-$132.00M-0.11%N/A
View Top Medical Stocks

RGEN earnings dates

Next earnings date
Apr 30, 2024

Repligen Earnings & Revenue FAQ

What were RGEN's earnings last quarter?

On Invalid Date, Repligen (NASDAQ: RGEN) reported Q4 2023 earnings per share (EPS) of -$0.45, up 151.72% year over year. Total Repligen earnings for the quarter were -$25.49 million. In the same quarter last year, Repligen's earnings per share (EPS) was $0.87.

If you're new to stock investing, here's how to buy Repligen stock.

What was RGEN's earnings growth in the past year?

As of Q2 2024, Repligen's earnings has grown -77.61% year over year. This is 100.41 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 22.79%. Repligen's earnings in the past year totalled $41.58 million.

What is RGEN's earnings date?

Repligen's earnings date is Invalid Date. Add RGEN to your watchlist to be reminded of RGEN's next earnings announcement.

What was RGEN's revenue last quarter?

On Invalid Date, Repligen (NASDAQ: RGEN) reported Q4 2023 revenue of $155.74 million up 16.61% year over year. In the same quarter last year, Repligen's revenue was $186.76 million.

What was RGEN's revenue growth in the past year?

As of Q2 2024, Repligen's revenue has grown -20.31% year over year. This is 28.3 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.99%. Repligen's revenue in the past year totalled $638.76 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.